subject in Medical Technology
Navigation Links
subject in Medical Technology
Multi-Center, Randomized Trial to Test Unique Delivery System Using Living Cells to Enhance Wound Healing Marks Milestone for Fort Worth, Texas-based Specialty Biopharmaceutical Company
FORT WORTH, Texas, June 16 /PRNewswire/ -- HEALTHPOINT, Ltd. today announced that it has enrolled the f...
- Phase II clinical trial investigating the effectiveness of Intercell's Vaccine Enhancement (VE) Patch in combination with an injectable H5N1 pandemic influenza vaccine started today in the U.S. - The study is fully funded by HHS - this is the second study conducted under a 5 year USD 128 m ...
HONG KONG, May 1 /PRNewswire/ -- The clinical impact of the first-ever pro-healing stent, OrbusNeich's Genous Bio-engineered R stent, is the subject of a symposium at next month's 16th Annual Scientific Congress of the Hong Kong College of Cardiology. Scheduled for May 3 at the Sheraton Hong...
...nts that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual...nt ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as s...
...nts that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual...t ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as s...
...rein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks a...
...(RED)ZONE area are available by visiting www.johnlegend.com/red and entering the special access code as prompted - tickets are $66.00 each and are subject to limited availability. Fans can log on to www.gap.com/johnlegend to locate participating Gap stores in the New York tri-state area. Gap...
...rein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks a...
...lease that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materi...ed or implied by such statements. In particular, clinical trial data are subject to differing interpretations, and the views of regulatory agencies, medical...
...ard-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual r...hey are not likely to be developed or commercialized for many years and are subject to further research and development; the need for additional development an...
...ctations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual re... or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ material...
...r implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors th...
... healthcare professionals in all countries except Japan and the access countries. Gilead will assume the lead role in manufacturing, registration and, subject to regulatory approval, commercialization of the fixed-dose combination of TMC278 and Truvada throughout the territory. Tibotec and Gilead ...
...rs in Fremont, California. For more information, visit www.velos.com . This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. * U....
...ments within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with the Company's abi...
...ds "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such ...
... In the Per-Protocol population (including subjects completing 8 minutes of treatment) the mean Visual Analog pain Scale (VAS) results recorded by the subject following the venipuncture procedure were 16.4 mm for the Active treatment versus 24.0 mm for the Placebo treatment (p=0.0235). Therefore, the trial d...
...covery in patients and physicians are closely examined in a series of articles and editorials in the July 2009 issue of Mayo Clinic Proceedings . The subject is especially timely. As the immense challenges, including potential tragedies, of prescription chemical addiction and abuse are being discussed, thes...
...nts that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual...t ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as s...
...itis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to...
...sitive results of the two Phase III trials are encouraging and suggest that subject to regulatory approval, this may offer a new treatment option for people wi... on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially d...
- Phase II clinical trial investigating the effectiveness of Intercell's Vaccine Enhancement (VE) Patch in combination with an injectable H5N1 pandemic influenza vaccine started today in the U.S. - The study is fully funded by HHS - this is the second study conducted under a 5 year USD 128 m ...
HONG KONG, May 1 /PRNewswire/ -- The clinical impact of the first-ever pro-healing stent, OrbusNeich's Genous Bio-engineered R stent, is the subject of a symposium at next month's 16th Annual Scientific Congress of the Hong Kong College of Cardiology. Scheduled for May 3 at the Sheraton Hong...
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
Latest Randomized Clinical Trial Results of First Pro-Healing Stent Also Featured at Annual Symposium HONG KONG, Oct. 18 /PRNewswire/ -- OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is the subject of several sessions about innovation in interventional cardiology stra...Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
... expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual......nts that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual...nt ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as s...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...nancial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and ...NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
...tion Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. F...accines can be sold in or outside the US; Novavax's pilot plant facility is subject to extensive validation and FDA inspections, which may result in delays and...2,500 Cases Completed With the Magnetic Irrigated Catheter
...elated to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their expr......nts that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual...t ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as s...
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...itis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to......rein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks a...
...(RED)ZONE area are available by visiting www.johnlegend.com/red and entering the special access code as prompted - tickets are $66.00 each and are subject to limited availability. Fans can log on to www.gap.com/johnlegend to locate participating Gap stores in the New York tri-state area. Gap...
Covance Receives Highest Level of Phase I Accreditation
...ncluding the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to an qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Th...European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK
...n management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified below) which are difficult to predict and, in many instances, are beyond the control of the Co......rein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks a...
...lease that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materi...ed or implied by such statements. In particular, clinical trial data are subject to differing interpretations, and the views of regulatory agencies, medical...
...ard-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual r...hey are not likely to be developed or commercialized for many years and are subject to further research and development; the need for additional development an...
...ctations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual re... or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ material...
...r implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors th...
... healthcare professionals in all countries except Japan and the access countries. Gilead will assume the lead role in manufacturing, registration and, subject to regulatory approval, commercialization of the fixed-dose combination of TMC278 and Truvada throughout the territory. Tibotec and Gilead ...
...rs in Fremont, California. For more information, visit www.velos.com . This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. * U....
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
...rein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks a......ments within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with the Company's abi...
deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
...rmance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the for......ds "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such ...
Is Obesity an Oral Bacterial Disease?
...seems likely that these bacterial species could serve as biological indicators of a developing overweight condition. Of even greater interest, and the subject of future research, is the possibility that oral bacteria may participate in the pathology that leads to obesity. The complete research study is ...... In the Per-Protocol population (including subjects completing 8 minutes of treatment) the mean Visual Analog pain Scale (VAS) results recorded by the subject following the venipuncture procedure were 16.4 mm for the Active treatment versus 24.0 mm for the Placebo treatment (p=0.0235). Therefore, the trial d...
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
...body reinforces and remodels the tissue. In the past, tissue replacement has been limited by options for implantation. Animal tissue implants are subject to calcium deposition and hardening, due to the body's ability to recognize them as foreign. Synthetic material lacks the performance characteristics ......covery in patients and physicians are closely examined in a series of articles and editorials in the July 2009 issue of Mayo Clinic Proceedings . The subject is especially timely. As the immense challenges, including potential tragedies, of prescription chemical addiction and abuse are being discussed, thes...
...nts that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual...t ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as s...
...itis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to...
Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy
...ic to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for ...ellectual property rights; and (x) intense competition. The Company is also subject to the risks and uncertainties described in its filings with the Securities...Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
...orm Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK's operations are descr...Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
...rein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks a...5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
... expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual...Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
...t the views of the management of NovaBay and Alcon as of the date of this press release with respect to future events and are based on assumptions and subject to significant risks and uncertainties (many of which are outside of NovaBay's or Alcon's control), including the risk that FDA or other regulatory re...deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
...rmance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the for...Sanofi-aventis Stands Behind the Safety of Lantus(R)
... expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual......sitive results of the two Phase III trials are encouraging and suggest that subject to regulatory approval, this may offer a new treatment option for people wi... on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially d...
Other TagsCrackerCurettePolisherOther Contentspersonalpersonalpersonalpersonalpersonalpersonalpersonalpersonalpersonalpesticidespesticidespesticidespesticidesperniciousmalmalpetitpharmacologypharmacologypharmacologypharmacologypharmacologypharmacologypharmacistpharmacistpharmacistpharyngitis
DelineatorCrackerTenotomyObliqueReclusDetachmentGassExpressorCurettePolisherCottinghamrelapsedProphesyRenamed
(Date:11/25/2009)...e California Institute of Technology (Caltech) hav...ehavior in the fruit fly, Drosophila melanogaster...e relationship between the neurotransmitter dopami...DHD), are described in the December issue of the j...ns only about 20,000 neurons and has long been con...
(Date:11/25/2009)... easy lives. In addition to mammalian immune syste...s called bacteriophages, viruses that kill half th...cteria and another class of microorganisms called ...such as deep-sea volcanic vents) manage just fine,...efense system that helps protect them from many vi...
(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Armed Forces Retirement Home Selects Millenniums Pharmacy Services 50586 1Armed Forces Retirement Home Selects Millenniums Pharmacy Services 50586 2TrinityCare Senior Living Inc Information to be Available Through Standard 26 Poors Market Access Program 50582 1TrinityCare Senior Living Inc Information to be Available Through Standard 26 Poors Market Access Program 50582 2The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 50578 1The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 50578 2(Date:11/25/2009)... When most people hear t...a chiropractor can also give patients the help the...nt, which is where your jaw (mandible) contacts/co... most common symptoms associated with TMJ dysfunct...the jaw. But many other symptoms can be caused fr...
(Date:11/25/2009)...Nov. 25 Onyx Pharmaceu... the company will host two investor events in Dece...2009 - 9:00 a.m. CT/10:00 a.m. ET ,, Principa...rrounding carfilzomib in relapsed and/or refractor...an Society of Hematology (ASH) Annual Meeting and ...
(Date:11/25/2009)...wswire/ - Sentinelle Medical Inc., a leading manuf...tion software launches a suite of new leading edge...aging software platform at this year,s Radiologica...n Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hal...ality images generated by Sentinelle,s specialized...
(Date:11/25/2009)...Newswire-USNewswire/--AnarticlebyJanetWoodcock,M.D...arch,titled"ADifficultBalance-PainManagement,DrugS...NewEnglandJournalofMedicine. ,, (Logo: http://w..., Inthearticle,WoodcockdiscussesFDAeffortstostrik...eeditandmanagingtherisksposedbyvariousanalgesics.A...
(Date:11/25/2009)...5 The Bay Area Air Quality Managem... Spare the Air Alert for Thursd...ufactured firelogs or any other solid fuel, both i...ll contribute to unhealthy air quality tomorrow," ...District. "We,re asking Bay Area residents to resp...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2[1] TMJ and Chiropractic Care: An Overall Wellness Approach[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |